Share on StockTwits
 

Teva Pharmaceutical Industries (NASDAQ:TEVA) declared a dividend on Tuesday, February 4th, AR Network reports. Stockholders of record on Monday, February 24th will be given a dividend of 0.34 per share on Monday, March 10th. The ex-dividend date of this dividend is Thursday, February 20th.

A number of research firms have recently commented on TEVA. Analysts at Leerink Swann raised their price target on shares of Teva Pharmaceutical Industries from $42.00 to $48.00 in a research note on Monday. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Teva Pharmaceutical Industries in a research note on Friday, February 7th. They now have a $47.00 price target on the stock. Finally, analysts at TheStreet upgraded shares of Teva Pharmaceutical Industries from a “hold” rating to a “buy” rating in a research note on Wednesday, January 29th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $45.71.

Teva Pharmaceutical Industries (NASDAQ:TEVA) opened at 43.85 on Friday. Teva Pharmaceutical Industries has a 1-year low of $36.26 and a 1-year high of $45.98. The stock has a 50-day moving average of $43.00 and a 200-day moving average of $40.02. The company has a market cap of $37.185 billion and a price-to-earnings ratio of 29.58.

Teva Pharmaceutical Industries (NASDAQ:TEVA) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.42 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.26 by $0.16. The company had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.19 billion. During the same quarter last year, the company posted $1.32 earnings per share. Teva Pharmaceutical Industries’s revenue was up 2.9% compared to the same quarter last year. On average, analysts predict that Teva Pharmaceutical Industries will post $4.61 earnings per share for the current fiscal year.

Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) is a global pharmaceutical and drug company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.